FDA Inspection 806442 — Xellia Pharmaceuticals ApS
The FDA completed an inspection of Xellia Pharmaceuticals ApS on October 16, 2012 in Copenhagen S. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 16, 2012
- Fiscal Year
- 2013
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Copenhagen S (Denmark)